insight into the cause of breathing pauses.
Apnea is a common condition in preterm infants, as their respiratory control system is not yet fully developed. While many breathing pauses are harmless, some episodes can result in serious drops in oxygen levels. For healthcare professionals, it is therefore important not only to detect when an apnea event occurs, but also to understand its underlying cause. Different types of apnea require different treatment strategies.
The patented method builds on SERA (Surface Electromyography Respiratory Assist) technology, which measures the electrical activity of the diaphragm through skin electrodes. This enables continuous monitoring of a patient's respiratory activity.
from innovation to clinical application.
The operating principle of the technology has already been successfully demonstrated. Over the coming period, Demcon macawi respiratory systems will focus on further development and validation, with the aim of ultimately integrating the method into the SERA system and making it suitable for everyday clinical practice.
With this new patent, Demcon macawi respiratory systems once again demonstrates how technological innovation can contribute to improved care for the most vulnerable patients.